Stay Informed About Key Developments for Our Company

The Latest Updates as They Happen

As a valued partner in our shared success, you should be the first to know what’s happening across our company. The articles and announcements below offer a comprehensive glimpse into the recent developments that shape our business and growth strategies.

 

Subscribe To Our Latest Investor News

News Highlights
January 13, 2021
Virtual Bayer Pharma Media Day:

Bayer transforms pharma business through breakthrough innovation in healthcare

READ MORE
January 12, 2021

U.S. FDA grants Priority Review to New Drug Application for finerenone

READ MORE
January 7, 2021

Bayer issues new senior bonds with a volume of 4 billion euros

READ MORE
January 7, 2021

CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV

Read more
AD HOC

Discover Bayer’s Latest Ad Hoc Releases

READ MORE
Explore All
81 - 90of about 600 News
81 - 90of about 600 News
November 07, 2019
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN
Bayer refinances 1.75 billion euro hybrid bond
READ MORE
November 04, 2019
Bayer completes sale of Dr. Scholl’s™ brand to Yellow Wood Partners
READ MORE
October 30, 2019
Third quarter of 2019
Bayer: Encouraging business performance across all divisions – agreements signed to divest Currenta and Animal Health
READ MORE
October 14, 2019
Not intended for U.S. and UK Media
U.S. FDA approves rivaroxaban to help prevent blood clots in acutely ill medical patients
READ MORE
October 01, 2019
Ertharin Cousin to become member of Bayer AG Supervisory Board
READ MORE
September 28, 2019
Not intended for U.S. and UK Media - European Society for Medical Oncology (ESMO) Congress 2019
Updated analysis for larotrectinib confirms high response rate and durable responses over three years in children and adults with TRK fusion cancer
READ MORE
September 23, 2019
Not intended for U.S. and UK Media
Vitrakvi® (larotrectinib) receives first tumor-agnostic approval in EU
READ MORE
September 20, 2019
Not intended for U.S. and UK Media - European Society for Medical Oncology (ESMO) Congress 2019
Bayer data at ESMO 2019 highlights innovation in cancer research
READ MORE
September 10, 2019
Changes to Board of Management structure as of January 1, 2020:
Bayer reduces size of Board of Management from seven to five members
READ MORE
September 02, 2019
Not intended for U.S. and UK Media - New guidelines from the European Society of Cardiology (ESC):
Xarelto™ 2.5 mg plus aspirin recommended for patients at high risk of heart attacks, strokes and death due to chronic coronary syndromes
READ MORE
81 - 90of about 600 News
81 - 90of about 600 News